Keyphrases
High Myopia
100%
Myopic Choroidal Neovascularization (mCNV)
63%
Ophthalmologist
63%
Macular Neovascularization
47%
Best-corrected Visual Acuity
44%
Risk Factors
35%
Myopia
35%
Empowered Patient
31%
Course Effect
31%
Natural Treatment
31%
Second Eye Involvement
31%
Serous Maculopathy
31%
Bevacizumab Therapy
31%
Long-term Treatment Outcomes
31%
Natural Course
31%
Central Serous Chorioretinopathy
31%
Posterior Staphyloma
31%
Treatment Effect
31%
Serous Retinal Detachment
31%
Patient Education
31%
White Patients
31%
Dutch
31%
Highly Myopic
28%
Hazard Ratio
28%
Spherical Equivalent
26%
Cumulative Incidence
22%
Alarm Symptoms
21%
Acute Events
21%
Patient Delay
21%
Netherlands
19%
Multiple Choice Questions
18%
Visual Prognosis
16%
Incidence Rate
15%
Fellow Eye
15%
Confidence Interval
15%
Retrospective Analysis
14%
Patient Organizations
14%
Self-reported Data
14%
Care Chain
14%
Intravitreal Bevacizumab
12%
Patchy Chorioretinal Atrophy
11%
Emmetropia
11%
Long-term Consequences
10%
Impact on Patients
10%
Second Sight
10%
Axial Length
10%
Doctor's Delay
10%
Lacquer Cracks
10%
Ophthalmic Care
10%
Visual Acuity Change
9%
Medicine and Dentistry
High Myopia
73%
Multiple Choice Test
36%
Symptom
31%
Staphyloma
31%
Exudative Retinal Detachment
31%
Maculopathy
31%
Treatment Effect
31%
Cumulative Incidence
31%
Hazard Ratio
31%
Central Serous Retinopathy
31%
Paint
21%
Eye Care
21%
Best Corrected Visual Acuity
18%
Physician
15%
Agents Acting on the Eye
15%
Outpatient
10%
Scanning Electron Microscopy
10%
Personal Experience
10%
Clinician
10%
Clinical Guideline
10%
Psychological Well-Being
10%
Macular Degeneration
10%
Proportional Hazards Model
10%
Awareness
10%
Nursing and Health Professions
High Myopia
63%
Ophthalmologist
63%
Patient Education
31%
Central Serous Retinopathy
31%
Hospital
31%
Symptom
21%
Multiple Choice Test
18%
Physician
10%
Agents Acting on the Eye
10%
Eye Care
7%
Imaging
6%
Choroidal Thickness
6%
